Nasdaq: GILD

Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker GILD. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
GILD
Exchange
Nasdaq
SEC CIK
882095
Official filings
SEC EDGAR

Research GILD

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Gilead Sciences, Inc.'s stock ticker?

Gilead Sciences, Inc. trades under the ticker symbol GILD on Nasdaq. Its SEC Central Index Key (CIK) is 882095.

Where can I read Gilead Sciences, Inc.'s SEC filings?

The GILD SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Gilead Sciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze GILD's financial statements?

The GILD Financials page shows Gilead Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does GILD compare with its peers and the market?

The GILD Peer Comparison page lines Gilead Sciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500 and Nasdaq.

For information only — not investment advice.